이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Austar Lifesciences 대차 대조표 상태
재무 상태 기준 확인 3/6
Austar Lifesciences 의 총 주주 지분은 CN¥775.5M 이고 총 부채는 CN¥430.7M, 이는 부채 대 자기자본 비율을 55.5% 로 가져옵니다. 총자산과 총부채는 각각 CN¥2.2B 및 CN¥1.4B 입니다.
주요 정보
55.5%
부채 비율
CN¥430.68m
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥173.77m |
| 주식 | CN¥775.47m |
| 총 부채 | CN¥1.38b |
| 총 자산 | CN¥2.16b |
최근 재무 상태 업데이트
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23재무 상태 분석
단기부채: 6118 의 단기 자산 ( CN¥1.6B )이 단기 부채( CN¥1.2B ).
장기 부채: 6118 의 단기 자산( CN¥1.6B )이 장기 부채( CN¥205.8M ).
부채 대 자본 내역 및 분석
부채 수준: 6118 의 순부채 대 자기자본 비율( 33.1% )은 satisfactory로 간주됩니다.
부채 감소: 6118 의 부채 대 자기자본 비율은 지난 5년간 5.4% 에서 55.5% 로 증가했습니다.
부채 범위: 6118 의 영업현금흐름이 마이너스이므로 부채가 제대로 상환되지 않습니다.
이자 보장: 6118 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.